281 related articles for article (PubMed ID: 34576068)
1. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).
Gong S; Duan Y; Wu C; Osterhoff G; Schopow N; Kallendrusch S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576068
[TBL] [Abstract][Full Text] [Related]
2. Integrated Profiling Identifies
Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
Front Immunol; 2021; 12():722807. PubMed ID: 34646265
[TBL] [Abstract][Full Text] [Related]
3. PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma.
Deng X; Pan Y; Yang M; Liu Y; Li J
Biomed Res Int; 2021; 2021():4714526. PubMed ID: 34239923
[TBL] [Abstract][Full Text] [Related]
4. PLOD3 is Upregulated in Gastric Cancer and Correlated with Clinicopathologic Characteristics.
Wang B; Xu L; Ge Y; Cai X; Li Q; Yu Z; Wang J; Wang Y; Lu C; Wang D; Wang Y; Chen X; Gu Y
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775879
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression.
Xie D; Li J; Wei S; Qi P; Ji H; Su J; Du N; Zhang X
Mol Cell Probes; 2020 Oct; 53():101608. PubMed ID: 32585183
[TBL] [Abstract][Full Text] [Related]
6. PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
Guo T; Gu C; Li B; Xu C
Lab Invest; 2021 May; 101(5):564-569. PubMed ID: 33483598
[TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
8. PLOD3 promotes lung metastasis via regulation of STAT3.
Baek JH; Yun HS; Kwon GT; Kim JY; Lee CW; Song JY; Um HD; Kang CM; Park JK; Kim JS; Kim EH; Hwang SG
Cell Death Dis; 2018 Nov; 9(12):1138. PubMed ID: 30442941
[TBL] [Abstract][Full Text] [Related]
9. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
Chen R; Jiang M; Hu B; Fu B; Sun T
Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
[TBL] [Abstract][Full Text] [Related]
11. A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.
Yu C; You M; Zhang P; Zhang S; Yin Y; Zhang X
Cancer Med; 2021 Jul; 10(13):4629-4643. PubMed ID: 34121340
[TBL] [Abstract][Full Text] [Related]
12. PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway.
Baek JH; Yun HS; Kwon GT; Lee J; Kim JY; Jo Y; Cho JM; Lee CW; Song JY; Ahn J; Kim JS; Kim EH; Hwang SG
Cell Death Dis; 2019 Feb; 10(3):156. PubMed ID: 30770789
[TBL] [Abstract][Full Text] [Related]
13. Clinical Prognostic Value of the
Meng Y; Sun J; Zhang G; Yu T; Piao H
Front Mol Biosci; 2021; 8():770729. PubMed ID: 35265665
[TBL] [Abstract][Full Text] [Related]
14. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
Li G; Wang X; Liu G
Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
[TBL] [Abstract][Full Text] [Related]
15. PLOD3 regulates the expression of YAP1 to affect the progression of non-small cell lung cancer via the PKCĪ“/CDK1/LIMD1 signaling pathway.
Li WH; Huang K; Wen FB; Cui GH; Guo HZ; Zhao S
Lab Invest; 2022 Apr; 102(4):440-451. PubMed ID: 35039611
[TBL] [Abstract][Full Text] [Related]
16. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas.
Tsai CK; Huang LC; Tsai WC; Huang SM; Lee JT; Hueng DY
Oncotarget; 2018 Mar; 9(21):15705-15720. PubMed ID: 29644003
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the typical features of tubulovillous adenoma using in-depth quantitative proteomics analysis.
Zhang Y; Pan M; Li CY; Li JY; Ge W; Xu L; Xiao Y
Bioengineered; 2021 Dec; 12(1):6831-6843. PubMed ID: 34585630
[TBL] [Abstract][Full Text] [Related]
19. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
Front Immunol; 2021; 12():812713. PubMed ID: 35069601
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of
Li L; Li F; Xu Z; Li L; Hu H; Li Y; Yu S; Wang M; Gao L
Front Pharmacol; 2023; 14():1213891. PubMed ID: 37680718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
